Abstract
Editorials6 December 2011Comparative Effectiveness and Cost-Effectiveness of Strategies to Screen for Osteoporosis in Postmenopausal WomenJohn T. Schousboe, MD, PhD and Margaret L. Gourlay, MD, MPHJohn T. Schousboe, MD, PhDFrom Park Nicollet Institute for Research & Education, Park Nicollet Health Services, and University of Minnesota, Minneapolis, MN 55416, and University of North Carolina, Chapel Hill, NC 26599.Search for more papers by this author and Margaret L. Gourlay, MD, MPHFrom Park Nicollet Institute for Research & Education, Park Nicollet Health Services, and University of Minnesota, Minneapolis, MN 55416, and University of North Carolina, Chapel Hill, NC 26599.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-155-11-201112060-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Everything should be made as simple as possible, but not simpler.—Albert EinsteinThe U.S. Preventive Services Task Force recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors (1). However, screening recommendations lack evidence-based guidance about screening intervals and when screening should cease (1, 2). Furthermore, screening in younger postmenopausal women is left to the discretion of the clinician, with osteoporosis (3–5) and fracture (6, 7) risk assessment tools as a guide. Although the ...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call